US Stock MarketDetailed Quotes
AVTX Avalo Therapeutics
- 8.3300
- -0.7600-8.36%
Close Dec 27 16:00 ET
- 8.3300
- 0.00000.00%
Post 17:48 ET
87.16MMarket Cap0.09P/E (TTM)
9.2700High8.1000Low102.85KVolume9.1000Open9.0900Pre Close870.97KTurnover3.55%Turnover RatioLossP/E (Static)10.46MShares34.460052wk High4.14P/B24.11MFloat Cap3.950152wk Low--Dividend TTM2.89MShs Float22031.7120Historical High--Div YieldTTM12.87%Amplitude3.9501Historical Low8.4680Avg Price1Lot Size
Avalo Therapeutics Key Stats
EPS
According to the latest financial report of Avalo Therapeutics, the latest earnings per share (TTM) for the company is -2.83. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Avalo Therapeutics's free cash flow? The latest report shows it as -11.53M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Avalo Therapeutics shows that the company's current ratio is 1.42, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Avalo Therapeutics, the quick ratio is 1.37, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Avalo Therapeutics? The latest ROE figure is 146.28%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Avalo Therapeutics, the total asset return on investment (ROA) is 5.28%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Avalo Therapeutics's latest financial report to see how their gross margin is doing - currently at 386.75%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Avalo Therapeutics, the net profit margin is 9.25K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Heat List
US
Overall
Symbol
Price
% Chg
No Data